HC upholds its earlier order on asthma drug Indamet against Glenmark Pharma
Sun Pharma Laboratories, a wholly-owned subsidiary of Sun Pharmaceutical Industries, and Glenmark are contesting over their right to use drug names “Istamet” and “Indamet”, respectively, which Sun Pharma finds to be deceptively similar and confusing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 17, 2024 Category: Pharmaceuticals Source Type: news
COVID Does Not Spur Asthma in Kids, Study Finds
WEDNESDAY, April 17, 2024 -- There ’s no evidence that a COVID infection increases the risk of asthma in children, the first study to date on the subject finds.“We knew from a number of really nice studies over the last decade or more that... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 17, 2024 Category: General Medicine Source Type: news
FDA Adds Fasenra Indication for Severe Asthma in Children
TUESDAY, April 16, 2024 -- The U.S. Food and Drug Administration has approved an additional indication for Fasenra (benralizumab) as an add-on maintenance treatment for patients aged 6 to 11 years with severe asthma and an eosinophilic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 16, 2024 Category: Pharmaceuticals Source Type: news
The U.K. Advances Bill that Would Create World ’s Only Generational Smoking Ban
The U.K. House of Commons voted Tuesday to advance the “Tobacco and Vapes Bill” that would make it illegal for anyone born in 2009 or beyond to buy tobacco and add restrictions to vaping. Legislators voted in favor of the bill in a 383- to-67 vote.
The bill would amount to an effective lifetime ban on smoking for those under the age of 15 and has now moved forward from its second reading to the committee stage.
[time-brightcove not-tgx=”true”]
“This isn’t about freedom to choose, it’s about freedom [from] addiction,” said Minister Andrea Leadsom during the ...
Source: TIME: Health - April 16, 2024 Category: Consumer Health News Authors: Anna Gordon and Solcyré Burga Tags: Uncategorized News News Desk Source Type: news
The U.K. to Vote on World ’s Only Generational Smoking Ban
The U.K. House of Commons will vote Tuesday on the “Tobacco and Vapes Bill” that would make it illegal for anyone born in 2009 or beyond to buy tobacco and add restrictions to vaping. Its passage would amount to an effective lifetime ban on smoking for those under the age of 15.
The bill was backed by Conservative Prime Minister Rishi Sunak, who has referred to tobacco as “the single biggest entirely preventable cause of ill-health, disability, and death.”
[time-brightcove not-tgx=”true”]
While the bill has support from lawmakers from both the opposition Labour and ruling Conserv...
Source: TIME: Health - April 16, 2024 Category: Consumer Health News Authors: Anna Gordon Tags: Uncategorized News News Desk Source Type: news
Family Allergy and Asthma to close two area locations
The closures come on the heels of an aggressive expansion by the company, which made at least three acquisitions in 2022 alone. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 16, 2024 Category: Pharmaceuticals Authors: Joel Stinnett Source Type: news
What Are Platanus Cough and Thunderstorm Asthma? What Are Platanus Cough and Thunderstorm Asthma?
Clinicians should learn to recognize and manage two conditions that climate change is making more common.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 15, 2024 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
Commentary: Pharmacy benefit managers, not Big Pharma, responsible for high drug prices
The media has written extensively about GSK's decision to stop selling its branded asthma inhaler Flovent and to replace it with a generic version. Outlets such as Fox Business and U.S. News and World Report have reported on the topic, but, remarkably, the stories fail to enlighten readers on why GSK chose to switch to a cheaper generic version of its inhaler.
Many of the stories seem to have been written by the same reporters, with industry critics regularly quoted and the blame falling predictably … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: William S. Smith | Robert Popovian Source Type: news
Planning Safe Summer Camp Fun for Kids With Allergies & Asthma
SATURDAY, April 13, 2023 -- Preparing a kid for summer camp is already a daunting task, and it ’s even more complicated if your child has allergies or asthma, experts say.“Kids with allergies and asthma need an extra layer of protection when... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 13, 2024 Category: General Medicine Source Type: news
COVID Infection Not Linked to New Asthma Diagnoses in Kids
(MedPage Today) -- A positive polymerase chain reaction (PCR) result for SARS-CoV-2 was not associated with a new asthma diagnosis in children, according to a retrospective cohort study.
In adjusted analyses, PCR positivity for SARS-CoV-2 had... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - April 12, 2024 Category: Pediatrics Source Type: news
SARS-CoV-2 Positivity Not Linked to New Asthma Diagnosis in Children
FRIDAY, April 12, 2024 -- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) positivity in children is not associated with an increased risk for new asthma diagnosis, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2024 Category: Pharmaceuticals Source Type: news
Fasenra Approved for Treatment of Children Aged 6 to 11 with Severe Asthma
WILMINGTON, Del.--(BUSINESS WIRE) April 11, 2024 --AstraZeneca’s Fasenra® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on maintenance treatment for patients with severe asthma aged 6 to 11 with an... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 11, 2024 Category: Drugs & Pharmacology Source Type: news
FDA Expands Benralizumab Use for Asthma to Kids Over Age 6 FDA Expands Benralizumab Use for Asthma to Kids Over Age 6
The maintenance treatment for severe asthma with an eosinophilic phenotype originally was approved for patients aged 12 years and older.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 11, 2024 Category: Allergy & Immunology Tags: Pediatrics News Alert Source Type: news
FDA Expands Approval of Severe Asthma Drug
(MedPage Today) -- The FDA expanded the approval of benralizumab (Fasenra) to include treatment of younger kids with uncontrolled severe asthma with an eosinophilic phenotype, AstraZeneca announced on Thursday.
Previously approved for individuals... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - April 11, 2024 Category: Allergy & Immunology Source Type: news
Long Covid trials aim to clear lingering virus —and help patients in need
One Monday morning last September, Shelley Hayden pulled into a parking spot in an underground garage at the University of California San Francisco (UCSF). She switched off the ignition, pushed the red record button on her cellphone, and gazed into the camera. “The time has come,” said Hayden, long dark-blond hair framing her blue eyes. “Here we are, I’m actually getting to do something.”
More than 3 years earlier, in the summer of 2020, Hayden had come down with COVID-19 while visiting family in Colorado. Since then she’s been plagued by the disease’s cruel sequel, Long Covid, whose symptoms include ov...
Source: ScienceNOW - April 11, 2024 Category: Science Source Type: news
